In a move to combat the opioid epidemic, Express Scripts announced measures to restrict access to prescription painkillers. However, they failed to act sooner, raising questions about prior inaction.
The New York Times investigation reveals that pharmacy benefit managers (P.B.M.s) were paid by drug manufacturers like Purdue Pharma to keep the flow of opioids unrestricted, contributing to the crisis.
These middlemen, known as P.B.M.s, wield significant power over prescription access and pricing, and have reaped billions while the overdose crisis escalated.
The details of the confidential agreements between P.B.M.s and opioid manufacturers provide insight into a largely hidden aspect of the opioid epidemic, prompting scrutiny on corporate responsibility.
#opioid-epidemic #pharmacy-benefit-managers #healthcare-industry #drug-manufacturers #prescription-crisis
Collection
[
|
...
]